Hunter syndrome is a rare X-linked recessive disorder caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to progressive accumulation of a substance called glycosaminoglycans in nearly all cell types, tissues, and organs. Hunter syndrome presents with facial dysmorphism, airway diseases, skeletal defects, cardiomyopathies, and neuropsychiatric manifestations. Mental subnormality is a cardinal feature in Hunter syndrome. This is a progressive cognitive decline that is not amenable to enzyme replacement therapy. Due to progressive cognitive decline, training the children to improve the adaptive functioning is a challenge that creates immense stress for the caregivers. Patients with Hunter syndrome should undergo serial assessment of intellectual ability and may be trained accordingly.
CITATION STYLE
Garg, K., & Kar, S. K. (2016). Mental health perspectives of Hunter syndrome: Case reports of two biological siblings. Medical Journal of Dr. D.Y. Patil University, 9(4), 534–536. https://doi.org/10.4103/0975-2870.186068
Mendeley helps you to discover research relevant for your work.